| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 9,404 | 13,134 | 11,433 | 14,296 | | Cost of Revenue |
-
| 7,069 |
-
|
-
| | | Gross Profit |
-
| 6,065 | 11,433 | 14,296 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,194 | (2,184) | 4,879 | 4,081 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
| 141 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 8,108 | 6,554 | 10,215 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (1,870) | (20) | (1,612) | | Earnings Before Interest And Taxes | 6,177 | 6,351 | 6,554 | 10,215 | | Interest Expense |
-
| 4,236 | 4,645 | 5,771 | | Income Before Tax | 2,002 | 2,115 | 1,909 | 4,444 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,135 | 2,002 | 1,889 | 2,832 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,890 | 2,002 | 1,889 | 2,832 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,890 | $2,002 | $1,889 | $2,832 |
|
0.02% Nasdaq 0.00%
Income Statement
